Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Device, Marks Major Advance for Women’s Health
BURLINGTON, Mass. & New York–( BUSINESS WIRE )–Butterfly Network, Inc. (“Butterfly,” “The Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced that it has received approval from the US Food and Drug Administration (FDA) for its fully automated Gestational Age (GA) handheld solution. It marks an … Read more
